The artificial blood substitutes market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 25.6% in the forecast period of 2021 to 2028 and is expected to reach USD 30,560.42 thousand by 2028.
Artificial Blood Substitutes Market - Scope and Size:
The artificial blood substitutes market is segmented on the based on the product type, source, application and end user. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
· On the basis of product type, the global artificial blood substitutes market is segmented into perfluorocarbon (PFCs) and haemoglobin-based oxygen carriers (HBOCs). Perfluorocarbon (PFCs) is further segmented into performant. Haemoglobin-based oxygen carries (HBOCs) is further segmented into ox globin and hem pure. In 2021, the haemoglobin-based oxygen carriers (HBOCs) segment is expected to dominate the artificial blood substitutes market due to rising demand for blood substitutes which eliminates the blood typing and to overcome the shortage of human blood.
· On the basis of source, the global artificial blood substitutes market is segmented into human blood, animal blood, microorganism based recombinant HB, synthetic polymers and stem cells. In 2021, the animal blood segment is expected to dominate the artificial blood substitutes market due to availability of ample amount of source to produce artificial blood.
Get sample reports on:
Market Analysis and Insights- Artificial Blood Substitutes Market:
Artificial blood substitutes are also known as oxygen therapeutics or haemoglobin-based oxygen carriers. It is used to mimic the function of biological blood and to offer a substitute to blood transfusion. Artificial blood are used as a solution to replace transfusion of banked red blood cells and are designed to overcome the limitations such as shortage of blood sonar, high risk contamination, requirement of cross matching. The allogenic blood transfusions has multiple risks and can cause infectious transmission, transfusion reactions, transfusion related acute lung injury, delayed postoperative wound healing, immunomodulation and potential risk of cancer recurrence. It offers the promise of new and important life-saving medical treatments.
Artificial blood are produced from sources such as animal blood, human blood, microorganism’s recombinant Hob, stem cells and others. Artificial blood also offers several advantages over the human blood as it belongs to universal blood group and can be given to the patients regardless of their blood type. Also artificial blood substitutes don’t produce any immulogical reactions. Also, artificial blood substitute eliminates the risk of infectious diseases or contamination during transfusion and offers extended shelf life in comparison to the human blood as it can be stored for 3 years at room temperature or more while the human blood shelf life is short for 42 days. Artificial blood can be used for emergency situations and can be stored easily also is the perfect option for the patients who doesn’t accept blood from donors due to their religious beliefs.
Artificial Blood Substitutes Market - Country Level Analysis:
The countries covered in the artificial blood substitutes market report are the U.S., Mexico, France, Russia, Netherlands, rest of Europe, China, rest of Asia-Pacific, , South Africa, and rest of Middle East and Africa
Key Players - Artificial Blood Substitutes Market
Some of the major players operating in the Artificial Blood Substitutes Market are:
· HEMARINA
· Haemoglobin Oxygen Therapeutics LLC
· Acolyte, Inc.
· LLC “Disused”, European Medicines Agency
· OPK Biotech LLC
· Novo Pharma
· Prolong Pharmaceuticals, LLC
· Boston Therapeutics, Inc.
· Arum Biosciences
· OXYVITA Inc
· Nano Blood LLC
Get Full Access of Report:
https://www.databridgemarketresearch.com/reports/global-artificial-blood-substitutes-market
MAJOR TOC OF THE REPORT:
· Chapter One: Introduction
· Chapter Two: Market Segmentation
· Chapter Three: Market Overview
· Chapter Four: Executive Summary
· Chapter Five: Premium Insights
· Chapter Six: Global Autoclave Market by Product Procedure type
Get TOC of Report:
https://www.databridgemarketresearch.com/toc/?dbmr=global-artificial-blood-substitutes-market
Browse Related Reports:
Global Medical Cannabis Based Oil Extract-Infused Products Market
Global Pet Cancer Therapeutics Market
Global Cold Compression Therapy Market
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market.
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: [email protected]
